07Feb

D-dimer point-of-care testing for DVT considered ‘game-changer’ in ambulatory care

Radiometerlogo

Crawley, UK – 07 February 2019 – Radiometer Limited’s AQT90 FLEX analysers have been used in a successful trial to asses D-dimer point-of-care testing (POCT) for suspected lower limb deep vein thrombosis (DVT). The editorial piece, published in Emergency Nurse [1], describes a reduction in patient waiting times of up to 75%.

 

The article, authored by Neal Aplin, Advanced Clinical Practitioner at the Great Western Hospitals NHS Foundation Trust, describes how the Great Western Hospital’s ambulatory care unit (ACU) took over the provision of the DVT testing after the local community service closed in 2017. The ACU introduced the AQT90 FLEX in a bid to reduce waiting times which could be more than two hours for a laboratory D-dimer result. First and foremost, the POCT system was assessed for comparable clinical outcomes to the lab and patient safety. 

Radiometer’s AQT90 FLEX analyser was then implemented and successfully provided D-dimer testing in less than 21 minutes. This greatly reduced the length of patient stay and waiting times, enabling faster diagnoses and an improved patient experience. Neal commented, "The AQT90 is very user-friendly and its rapid diagnostic [IVD] ability has had a significant impact on improving our patient flow and experience." 

The resounding benefits gained from trialling the AQT90 FLEX analyser for DVT at the point of care were considered a 'game-changer' for the ACU. The analyser is now successfully being used to aid in the diagnosis of venous thromboembolism. Neal also notes that there is hope to expand POCT further in the ACU in the future.

To read the full article, please see the reference below. To find out more about Radiometer’s portfolio of tests and the AQT90 FLEX, please contact sales@radiometer.co.uk.

References:

1. Aplin NA. D-dimer testing for DVT is a game-changer in ambulatory care. Emergency Nurse 2018. https://rcni.com/emergency-nurse/opinion/comment/d-dimer-testing-dvt-a-game-changer-ambulatory-care-134181

About Radiometer:

Radiometer develops, manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and the related IT management systems. Radiometer’s products and services simplify and automate all phases of acute care testing, so hospitals can get fast results, optimise their workload, reduce the risk of errors, and improve cost effectiveness. For more information visit www.radiometer.co.uk.

Related

SpeeDx Receives CE-IVD Mark for ResistancePlus® GC

New molecular assay enables rapid antibiotic resistance result to support use of cost effective and ...

Read More >

FDA grants de novo designation for OGT’s AML/MDS FISH probes

Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burde...

Read More >

Study confirms HORIBA POCT analyser enables earlier clinical decision-making in emergency paediatrics

Northampton, UK – 20th March 2018 – HORIBA UK Ltd, Medical announces that in a study recently unde...

Read More >

SpeeDx and Thermo Fisher Scientific announce strategic partnership for FDA clearance of molecular diagnostic test

SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement ...

Read More >

New Blood Collection Tubes Stabilise Nucleated Blood Cells

The new Streck Cell-Free DNA BCT® CE blood collection tubes, now available in the UK from Alpha Labo...

Read More >

The TOPRA Annual Symposium

The TOPRA Annual Symposium is the largest forum for European regulatory professionals to meet up, di...

Read More >